Sort   by:  
 Page size 
ProteomicsMembrane enriched temperature series proteome of Francisella tularensis subspecies novicida in wild type and lipid A acyltransferase null mutants.
Quantitative proteomics has matured into an established tool and longitudinal proteomic experiments have begun to emerge. However, no effective, simple-to-use differential expression method for longitudinal proteomics data has been released. Typically, such data is noisy, contains missing values, ha...
ORGANISM(S): Francisella tularensis subsp. novicida (strain U112) 
2023-01-24 | PXD025439 | Pride
Francisella tularensis subspecies novicida Lpxd1 Lipid a Knockout Lpxd2 Francisella novicida Orbitrap elite Temperature series Lpxl Francisella tularensis 
ProteomicsProteomic and phosphoproteomic analysis of cisplatin resistance in patient derived serous ovarian cancer
Understanding the mechanism of resistance in platinum-based regimens for the treatment of high-grade serous ovarian cancer (HGSOC) is important for identifying new therapeutic targets to improve the clinical outcome of ovarian cancer patients. Mass spectrometry-based proteomic strategy was applied t...
ORGANISM(S): Homo sapiens (Human) 
2017-05-02 | PXD002394 | Pride
Phosphoproteomic Resistance Ovarian cancer Cisplatin Ms/ms 
ProteomicsPvM1
Yeast: identification of peroxisomal proteins with subcellular fractionation and tandem mass spectrometry. ICAT labeled peptides.
ORGANISM(S): Saccharomyces Cerevisiae 
2004-12-31 | PAe000128 | PeptideAtlas
ProteomicsOne-Pot Isotope Dilution PRM for Quantitative Protein Heterogeneity in Red Blood Cells
Single cell and low-input cell proteomics to measure cellular heterogeneity remains experimental and requires further refinement for routine application. This study aimed to build on previous protocols to assess the utility of targeted proteomics for measuring heterogeneity in red blood cells (RBCs)...
ORGANISM(S): Homo Sapiens 
2024-02-06 | PXD030875 | panorama
ProteomicsEstablishing personalized blood protein reference ranges using non-invasive microsampling and targeted proteomics: Implications for anti-doping strategies
To prevent doping practices in sports, the World Anti-Doping Agency implemented the Athlete Biological Passport (ABP) program, monitoring biological variables over time to indirectly reveal effects of doping rather than detect the doping substance or method itself. In the context of this program an...
ORGANISM(S): Homo Sapiens 
PXD048168 | panorama
ProteomicsD12_iTRAQ
D12_1 and D12_2 are 8 plex iTRAQ analyses of depleted serum samples. The files are mgf files of collected SCX fractions that were analyzed with an Orbitrap Velos- Proxeon capillary LC combination. HCD fragmentation was used.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2014-06-24 | MSV000078759 | MassIVE
ProteomicsD14_LF
RAW files Case19T and Control19T represent D14 and Control-14 and are marked by their visit number. These are label free analyses of depleted serum samples conducted with an Orbitrap Velos- Proxeon capillary LC combination. CID fragmentation was used.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2014-06-24 | MSV000078760 | MassIVE
ProteomicsLongitudinal study
iTRAQ labelled depleted serum, SCX fractionated, RP-LC Orbitrap-Velos
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2014-06-23 | MSV000078746 | MassIVE
ProteomicsD8_iTRAQ
D1_1 and D1_2 are 8 plex iTRAQ analyses of depleted serum samples. The files are mgf files of collected SCX fractions that were analyzed with an Orbitrap Velos- Proxeon capillary LC combination. HCD fragmentation was used.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2014-06-24 | MSV000078754 | MassIVE
ProteomicsD16_LF
Thermo RAW files Case2T and Control2T (CS and CO) represent D16 and Control-16 and are marked by their visit number. These are label free analyses of depleted serum samples conducted with an Orbitrap Velos- Proxeon capillary LC combination. CID fragmentation was used. The samples were analyzed in qu...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2014-06-25 | MSV000078762 | MassIVE
Sort   by:  
 Page size